Literature DB >> 13459572

Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases.

C A SWINYARD, G G DEAVER, L GREENSPAN.   

Abstract

Entities:  

Keywords:  PROGRESSIVE MUSCULAR DYSTROPHY/therapy

Mesh：

Year:  1957        PMID： 13459572

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN： 0003-9993            Impact factor:   3.966


× No keyword cloud information.
  23 in total

1.  A trial of therapy by nucleosides and nucleotides in muscular dystrophy.

Authors:  W H THOMSON; K E GUEST
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-04       Impact factor: 10.154

2.  A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy.

Authors:  P J VIGNOS; M LEFKOWITZ
Journal:  J Clin Invest       Date:  1959-06       Impact factor: 14.808

3.  Serum enzymes and genetic carriers in muscular dystrophy.

Authors:  C S CHUNG; N E MORTON; H A PETERS
Journal:  Am J Hum Genet       Date:  1960-03       Impact factor: 11.025

Review 4.  Genetic and clinical correlations of Xp21 muscular dystrophy.

Authors:  K M Bushby
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

5.  Increased mid-left ventricular rotation in patients with Duchenne muscular dystrophy using two-dimensional speckle tracking echocardiography.

Authors:  Tatsushi Miyazaki; Katsunori Tatara; Kazuhiro Mori; Miki Inoue; Yasunobu Hayabuchi; Shoji Kagami
Journal:  J Echocardiogr       Date:  2009-11-07

6.  Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy.

Authors:  Yaroslav Winter; Karsten Schepelmann; Annika E Spottke; Detlef Claus; Christoph Grothe; Rolf Schröder; Dieter Heuss; Stefan Vielhaber; Björn Tackenberg; Veit Mylius; Jens-Peter Reese; Reinhard Kiefer; Bertold Schrank; Wolfgang H Oertel; Richard Dodel
Journal:  J Neurol       Date:  2010-04-10       Impact factor: 4.849

7.  Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy.

Authors:  D Rudman; S B Chyatte; J H Patterson; G G Gerron; I O'Beirne; J Barlow; A Jordan; J S Shavin
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

8.  Assisted cough and pulmonary compliance in patients with Duchenne muscular dystrophy.

Authors:  Seong Woong Kang; Yeoun Seung Kang; Jae Ho Moon; Tae Won Yoo
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

9.  Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment.

Authors:  Hee Kyung Kim; Tal Laor; Paul S Horn; Brenda Wong
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

10.  Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy.

Authors:  Karsten Schepelmann; Yaroslav Winter; Annika E Spottke; Detlef Claus; Christoph Grothe; Rolf Schröder; Dieter Heuss; Stefan Vielhaber; Veit Mylius; Reinhard Kiefer; Bertold Schrank; Wolfgang H Oertel; Richard Dodel
Journal:  J Neurol       Date:  2009-07-24       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.